Q2037 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)

Name of the Procedure:

Common Name: Flu Vaccine, Fluvirin
Technical/Medical Term: Influenza Virus Vaccine, Split Virus, Administered Intramuscularly (Q2037)

Summary

The flu vaccine, specifically Fluvirin, is an intramuscular shot administered to individuals aged 3 years and older to protect against influenza, commonly known as the flu.

Purpose

Medical Conditions: The flu vaccine is used to prevent influenza, a contagious respiratory illness caused by influenza viruses.
Goals/Outcomes: The goal is to reduce the risk of flu-related complications, hospitalizations, and the spread of the virus within the community.

Indications

Symptoms: High fever, cough, sore throat, muscle aches, fatigue.
Patient Criteria: Individuals aged 3 years and older, especially those with chronic health conditions, the elderly, pregnant women, and healthcare workers.

Preparation

Pre-Procedure Instructions: Generally, no specific preparations are needed. Inform your healthcare provider of any allergies or prior adverse reactions to vaccines.
Diagnostic Tests: None required, but a brief medical history review is essential.

Procedure Description

1. Preparation: The healthcare provider will prepare the Fluvirin vaccine.
2. Administration: The vaccine is injected into the muscle of the upper arm (deltoid muscle).
3. Equipment: Sterile needle and syringe, Fluvirin vaccine vial.
4. Anesthesia/Sedation: None required; the procedure is quick and minimally painful.

Duration

The injection process typically takes a few minutes.

Setting

The vaccine can be administered in various settings, including:

• Hospitals
• Outpatient Clinics
• Community Health Centers
• Pharmacies

Personnel

Typically administered by:

• Nurses
• Medical Assistants
• Pharmacists

Risks and Complications

Common Risks:

• Soreness at the injection site
• Mild fever
• Fatigue

Rare Risks:

• Severe allergic reactions (anaphylaxis)
• Guillain-Barré Syndrome (extremely rare)

Management: Any adverse reactions should be reported to the healthcare provider immediately.

Benefits

Expected Benefits:

• Reduced risk of contracting influenza
• Decreased severity if one does get flu Timeframe: Immunity generally develops within two weeks post-vaccination.

Recovery

Post-Procedure Care: Monitor the injection site for redness or swelling. Over-the-counter pain relief (e.g., acetaminophen) can be used if necessary.
Recovery Time: Immediate; individuals can typically resume normal activities right away.
Restrictions/Follow-up: None, but yearly vaccination is recommended.

Alternatives

Other Options:

• Live-attenuated influenza vaccine (nasal spray)
• Other intramuscular or intradermal flu vaccine brands

Pros and Cons:

• Nasal Spray: Suitable for those who fear needles but not for immunocompromised individuals.
• Other Brands: Equally effective but choice may depend on availability and individual health conditions.

Patient Experience

During Procedure: Brief discomfort from the needle prick.
After Procedure: Mild soreness at the injection site is common. Hydrate well and inform your healthcare provider of any unusual symptoms. Pain can usually be managed with OTC pain relievers.